D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.36% |
| 2 | Consumer Discretionary | 9.47% |
| 3 | Financials | 6.95% |
| 4 | Healthcare | 6.38% |
| 5 | Communication Services | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOGL
901
DELISTED
Golden Ocean Group
GOGL
| $17.8M | 0.02% |
1,369,606
+1,076,035
| +367% | +$12.4M |
|
902
Resideo Technologies
REZI
$5.19B
| $17.7M | 0.02% |
791,645
-30,843
| -4% | -$609K |
|
903
RxSight
RXST
$249M
| $17.7M | 0.02% |
342,980
+144,410
| +73% | +$7.09M |
|
904
IQVIA
IQV
$38.7B
| $17.6M | 0.02% |
69,744
+67,744
| +3,387% | +$15.8M |
|
905
PUT
Eaton
ETN
$161B
| $17.6M | 0.02% |
56,400
+46,000
| +442% | +$12.6M |
|
906
Builders FirstSource
BLDR
$7.15B
| $17.6M | 0.02% |
84,544
-7,730
| -8% | -$1.43M |
|
|
NVO
907
Novo Nordisk
NVO
$208B
| $17.5M | 0.02% |
136,673
+97,376
| +248% | +$11.6M |
|
908
Carrier Global
CARR
$51B
| $17.5M | 0.02% |
301,726
+229,428
| +317% | +$12.9M |
|
909
Prudential Financial
PRU
$42.4B
| $17.4M | 0.01% |
148,242
+65,145
| +78% | +$7.02M |
|
910
Comcast
CMCSA
$85B
| $17.4M | 0.01% |
401,420
+267,172
| +199% | +$11.5M |
|
|
YMAB
911
DELISTED
Y-mAbs Therapeutics
YMAB
| $17.4M | 0.01% |
1,068,159
-255,621
| -19% | -$3.45M |
|
|
SNBR
912
DELISTED
Sleep Number
SNBR
| $17.4M | 0.01% |
1,082,624
-4,341
| -0.4% | -$56.3K |
|
913
SM Energy
SM
$7.8B
| $17.3M | 0.01% |
347,944
-242,140
| -41% | -$9.9M |
|
|
SHYF
914
DELISTED
The Shyft Group
SHYF
| $17.3M | 0.01% |
1,392,964
+64,345
| +5% | +$717K |
|
915
CALL
SLB Ltd
SLB
$73.6B
| $17.3M | 0.01% |
315,100
-18,000
| -5% | -$907K |
|
916
InterDigital
IDCC
$7.87B
| $17.2M | 0.01% |
161,685
-236,739
| -59% | -$25M |
|
917
Moog Inc Class A
MOG.A
$12.4B
| $17.1M | 0.01% |
107,138
-19,289
| -15% | -$2.84M |
|
918
PUT
BioNTech
BNTX
$22.9B
| $17.1M | 0.01% |
185,300
+700
| +0.4% | +$67.1K |
|
919
PUT
Twilio
TWLO
$30B
| $17.1M | 0.01% |
279,100
-443,700
| -61% | -$29.2M |
|
920
CACI
CACI
$11B
| $17.1M | 0.01% |
45,011
-5,408
| -11% | -$1.92M |
|
921
PUT
AbbVie
ABBV
$443B
| $17M | 0.01% |
93,300
-333,800
| -78% | -$57.5M |
|
|
ALPN
922
DELISTED
Alpine Immune Sciences Inc
ALPN
| $17M | 0.01% |
428,555
+133,013
| +45% | +$3.92M |
|
923
Federated Hermes
FHI
$4.55B
| $17M | 0.01% |
469,396
-410,663
| -47% | -$14.4M |
|
924
Thomson Reuters
TRI
$42.8B
| $16.9M | 0.01% |
107,113
-41,639
| -28% | -$6.48M |
|
925
Axos Financial
AX
$5.77B
| $16.9M | 0.01% |
313,414
-32,683
| -9% | -$1.72M |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co withdrew a net $8.58B in Q1 2024, closing 634 positions and reducing 1,722 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $307M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Arm worth $297M.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.